Paratek Pharmaceuticals News

PRTKDelisted Stock  USD 2.18  0.00  0.00%   
About 56% of Paratek Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in Paratek Pharmaceuticals suggests that many traders are alarmed regarding Paratek Pharmaceuticals' prospects. Paratek Pharmaceuticals' investing sentiment shows overall attitude of investors towards Paratek Pharmaceuticals.
  
over a year ago at finance.yahoo.com         
Why Paratek Pharmaceuticals Stock Is Plunging Today
Yahoo News
over a year ago at investing.com         
Paratek Pharma earnings missed by 0.04, revenue topped estimates
Investing News at Macroaxis
over a year ago at kalkinemedia.com         
Paratek Pharmaceuticals Inc Losses of12 cents announced for fourth quarter
news
over a year ago at kalkinemedia.com         
Paratek Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
news
over a year ago at finance.yahoo.com         
Paratek Pharmaceuticals Reports Q4 Loss, Tops Revenue Estimates
Yahoo News
over a year ago at thefly.com         
Paratek Pharmaceuticals reports Q4 EPS , consensus 9c PRTK
news
over a year ago at thefly.com         
Paratek Pharmaceuticals sees FY23 revenue 143M-158M, consensus 232.02M PRTK
news
over a year ago at kalkinemedia.com         
Paratek Pharmaceuticals Announces Fourth Quarter 2022 Results
news
over a year ago at finance.yahoo.com         
Paratek Pharmaceuticals Announces Full-Year 2022 Revenue of 160.3 Million
Yahoo News
over a year ago at globenewswire.com         
Paratek Pharmaceuticals Announces Full-Year 2022 Revenue of 160.3 Million
Macroaxis News: globenewswire.com
over a year ago at globenewswire.com         
Paratek Pharmaceuticals Announces Full-Year 2022 Revenue of 160.3 Million
Macroaxis News: globenewswire.com
over a year ago at kalkinemedia.com         
Paratek Pharmaceuticals Inc expected to post earnings of9 cents a share - Earnings Preview
news
over a year ago at kalkinemedia.com         
Paratek Pharmaceuticals Inc Profits of9centsper share anticipated forfourth quarter
news
over a year ago at finance.yahoo.com         
Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on March 16
Yahoo News
over a year ago at finance.yahoo.com         
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635
Yahoo News
Far too much social signal, news, headlines, and media speculation about Paratek Pharmaceuticals that are available to investors today. That information is available publicly through Paratek media outlets and privately through word of mouth or via Paratek internal channels. However, regardless of the origin, that massive amount of Paratek data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Paratek Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Paratek Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Paratek Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Paratek Pharmaceuticals alpha.

Paratek Pharmaceuticals Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Paratek Pharmaceuticals Halted, News Pending
06/06/2023
2
NexPoint Asset Management Sends Open Letter to the Board of Paratek Pharmaceuticals Regarding Upcoming Annual Meeting and Proposed Acquisition by Gurnet Point C...
06/27/2023
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Consideration for investing in Paratek Stock

If you are still planning to invest in Paratek Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Paratek Pharmaceuticals' history and understand the potential risks before investing.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.